We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Receives Few Answers From Panel on Depression Devices
FDA Receives Few Answers From Panel on Depression Devices
October 15, 2010
In its quest to create consistency and transparency in designing clinical trials for devices intended to treat depression, the FDA received little help from a recently convened advisory panel.